X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30548) 30548
Publication (2845) 2845
Book Review (360) 360
Book / eBook (172) 172
Book Chapter (27) 27
Newsletter (24) 24
Conference Proceeding (20) 20
Dissertation (16) 16
Data Set (10) 10
Magazine Article (9) 9
Newspaper Article (3) 3
Paper (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28652) 28652
oncology (17916) 17916
female (16611) 16611
antineoplastic combined chemotherapy protocols - therapeutic use (16576) 16576
index medicus (14891) 14891
male (12230) 12230
middle aged (10708) 10708
adult (9114) 9114
aged (8856) 8856
chemotherapy (8552) 8552
animals (7754) 7754
cancer (7715) 7715
antineoplastic combined chemotherapy protocols - pharmacology (7164) 7164
pharmacology & pharmacy (6964) 6964
antineoplastic combined chemotherapy protocols - adverse effects (6319) 6319
cell line, tumor (5998) 5998
treatment outcome (5746) 5746
mice (5128) 5128
antineoplastic agents - pharmacology (4604) 4604
antineoplastic combined chemotherapy protocols - administration & dosage (4154) 4154
apoptosis (4118) 4118
drug synergism (3932) 3932
apoptosis - drug effects (3877) 3877
breast neoplasms - drug therapy (3414) 3414
therapy (3375) 3375
cisplatin - administration & dosage (3241) 3241
dose-response relationship, drug (3236) 3236
antineoplastic agents - therapeutic use (3166) 3166
research (3069) 3069
care and treatment (2886) 2886
cisplatin (2866) 2866
lung neoplasms - drug therapy (2830) 2830
fluorouracil - administration & dosage (2821) 2821
combined modality therapy (2790) 2790
cell proliferation - drug effects (2698) 2698
drug administration schedule (2691) 2691
disease-free survival (2690) 2690
tumors (2662) 2662
prognosis (2631) 2631
xenograft model antitumor assays (2577) 2577
aged, 80 and over (2462) 2462
doxorubicin - administration & dosage (2413) 2413
expression (2395) 2395
neoplasms - drug therapy (2338) 2338
survival analysis (2327) 2327
adolescent (2217) 2217
breast cancer (2164) 2164
neoplasm staging (2157) 2157
mice, nude (2144) 2144
drug therapy (2136) 2136
cyclophosphamide - administration & dosage (2109) 2109
carcinoma (2075) 2075
deoxycytidine - analogs & derivatives (2072) 2072
drug resistance, neoplasm (2072) 2072
survival (2068) 2068
medicine & public health (2065) 2065
health aspects (2040) 2040
cancer therapies (2024) 2024
survival rate (1989) 1989
antineoplastic agents (1968) 1968
breast neoplasms - pathology (1925) 1925
antineoplastic agents - administration & dosage (1920) 1920
pharmacology/toxicology (1892) 1892
trial (1855) 1855
analysis (1822) 1822
time factors (1812) 1812
combination (1754) 1754
carcinoma, non-small-cell lung - drug therapy (1750) 1750
cell survival - drug effects (1734) 1734
cancer research (1725) 1725
paclitaxel (1724) 1724
metastasis (1721) 1721
hematology (1718) 1718
paclitaxel - administration & dosage (1683) 1683
tumor cells, cultured (1654) 1654
medicine (1653) 1653
article (1647) 1647
antimitotic agents (1627) 1627
deoxycytidine - administration & dosage (1604) 1604
signal transduction - drug effects (1547) 1547
neoplasm metastasis (1514) 1514
clinical trials as topic (1509) 1509
research article (1498) 1498
doxorubicin (1479) 1479
colorectal neoplasms - drug therapy (1465) 1465
child (1453) 1453
pharmacology (1446) 1446
cells (1411) 1411
in-vitro (1405) 1405
lung neoplasms - pathology (1405) 1405
proteins (1399) 1399
toxicity (1394) 1394
clinical trials (1386) 1386
breast-cancer (1381) 1381
5-fluorouracil (1380) 1380
retrospective studies (1335) 1335
chemotherapy, adjuvant (1322) 1322
phase-ii (1321) 1321
fluorouracil (1313) 1313
gemcitabine (1311) 1311
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (131) 131
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
Online Resources - Online (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Credit Valley Hospital - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30107) 30107
Japanese (261) 261
Chinese (108) 108
French (71) 71
Russian (69) 69
German (50) 50
Spanish (38) 38
Italian (20) 20
Polish (14) 14
Hungarian (12) 12
Portuguese (6) 6
Croatian (4) 4
Swedish (4) 4
Hebrew (3) 3
Czech (1) 1
Finnish (1) 1
Korean (1) 1
Manx (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Advanced Materials, ISSN 0935-9648, 07/2013, Volume 25, Issue 27, pp. 3670 - 3676
Journal Article
Autophagy, ISSN 1554-8627, 08/2014, Volume 10, Issue 8, pp. 1380 - 1390
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2018, Volume 24, Issue 6, pp. 749 - 757
We describe results from IMmotion150, a randomized phase 2 study of atezolizumab (anti-PD-L1) alone or combined with bevacizumab (anti-VEGF) versus sunitinib... 
MEDICINE, RESEARCH & EXPERIMENTAL | MULTICENTER | PD-L1 EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHASE-III | SINGLE-ARM | CANCER | CELL BIOLOGY | PATHWAY | SUPPRESSOR-CELLS | NIVOLUMAB | TUMOR-GROWTH | ENDOTHELIAL GROWTH-FACTOR | Sunitinib - pharmacology | Bevacizumab - pharmacology | Kidney Neoplasms - genetics | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Renal Cell - genetics | Antibodies, Monoclonal - therapeutic use | Male | Gene Expression Profiling | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Aged, 80 and over | Adult | Female | Carcinoma, Renal Cell - drug therapy | Antibodies, Monoclonal - pharmacology | Kaplan-Meier Estimate | Treatment Outcome | Mutation - genetics | Sunitinib - adverse effects | Sunitinib - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Kidney Neoplasms - drug therapy | Development and progression | Dosage and administration | Angiogenesis inhibitors | Carcinoma, Renal cell | Comparative analysis | Drug therapy | Cell survival | Inflammation | Gene expression | Molecular chains | Bevacizumab | Metastases | Confidence intervals | Angiogenesis | Immune checkpoint | Immunotherapy | γ-Interferon | PD-L1 protein | Biomarkers | Bioindicators | Vascular endothelial growth factor | Clear cell-type renal cell carcinoma
Journal Article
Nature, ISSN 0028-0836, 09/2015, Volume 525, Issue 7569, pp. 380 - 383
Whether cancer is maintained by a small number of stem cells or is composed of proliferating cells with approximate phenotypic equivalency is a central... 
CANCER-CELLS | MAINTENANCE | ACTIVATION | HEMATOPOIESIS | PATHWAY | CITED2 | MULTIDISCIPLINARY SCIENCES | IMATINIB | STAT5 | DIFFERENTIATION | HIF-1-ALPHA | Piperazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cell Proliferation | Neoplastic Stem Cells - drug effects | Humans | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | PPAR gamma - metabolism | Thiazolidinediones - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | STAT5 Transcription Factor - metabolism | Benzamides - administration & dosage | Thiazolidinediones - therapeutic use | Benzamides - therapeutic use | Basic Helix-Loop-Helix Transcription Factors - metabolism | Neoplastic Stem Cells - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Neoplastic Stem Cells - pathology | Benzamides - pharmacology | Thiazolidinediones - pharmacology | Repressor Proteins - metabolism | Pyrimidines - administration & dosage | Piperazines - therapeutic use | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | PPAR gamma - agonists | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Trans-Activators - metabolism | Life Sciences | Microbiology and Parasitology | Immunology | Bacteriology | Virology
Journal Article
Cancer Cell, ISSN 1535-6108, 05/2018, Volume 33, Issue 5, pp. 853 - 861.e4
Journal Article